International Delivery — £35 per Order
Explore how the MHRA, FDA and EMA assess medicines, what approval means and where anti-doping rules apply to peptides.
Regulation & status
Learn the difference between FDA-approved peptides and experimental peptides. It includes clinical evidence, drug approval, manufacturing standards, safety risks, and peptide regulation.
Regulation & status
Learn how the FDA evaluates peptide medicines through clinical trials, IND and NDA reviews, manufacturing standards, purity testing, and safety assessments
Regulation & status
Understand what “Not FDA Approved” means for peptides and medicines. Learn about FDA approval status, investigational drugs, compounded products, research chemicals, and regulatory differences.
Regulation & status
Understanding peptide regulation in the UK, including MHRA approval rules, Human Medicines Regulation 2012, licensed peptide medicines, research peptides, Specials, and legal supply requirements.
Regulation & status
Compare FDA, EMA, and MHRA drug regulation systems. Learn how these agencies differ in medicine approval, clinical trials, peptide regulation, and global market access.
Regulation & status
Learn the difference between compounded peptides and FDA-approved medicines, including regulation, safety standards, 503A vs. 503B pharmacies, and quality controls.
Regulation & status
Learn why some peptides are restricted in competitive sport, how WADA classifies BPC-157, CJC-1295, and growth factors, and what anti-doping rules mean for athletes.
Regulation & status
Learn how WADA classifies peptide hormones, growth factors, BPC-157, TB-500, CJC-1295, GHRPs, and EPO under the 2026 Prohibited List.
